Batches of six different medicines have been pulled off the shelves in Abu Dhabi for failing to meet official specifications.
They include Amydramine paediatric syrup, Moxal Plus tablet, Julphamox 500 mg capsule, Julmentin 2X tablet, Rosuvastatin and Oxaliplatin.
These drugs are prescribed for the treatment of allergies, colon cancer, respiratory tract infections and lowering cholesterol.
The Department of Health (DoH) Abu Dhabi has asked pharmacies and hospitals to return their stock to the supplier.

UAE says reports of Israeli PM Netanyahu's visit 'entirely unfounded'
UAE launches platform to help Emiratis choose 'right academic, career paths'
Dubai Customs foils attempt to smuggle endangered bears through airport
UAE, Syria Presidents discuss cooperation and regional developments
UAE President, Qatari Emir discuss ties and regional developments
UAE reinforces anti-money laundering standards in gold sector
Eid Al Adha holidays confirmed for Dubai Government entities
UAE President holds talks with US, Saudi Arabia leaders
Dubai's Parkin begins roll out of AI curb-side parking cameras
UAE reviews AI readiness across federal government
From Sweden to India, 10 nurses shortlisted for $250,000 global award
UAE, Kuwaiti Foreign Ministers discuss foiled infiltration operation by Iran's IRGC
UAE adds 16 individuals, 5 entities to terror list over Hezbollah links
UAE fully prepared to deal with hantavirus, any health threats
UAE condemns IRGC's infiltration of Kuwait’s Bubiyan Island
Eid Al Adha holidays announced for public sector
Dubai aligns driver training with advanced vehicle systems
H.H. Sheikh Mohammed reviews Agentic AI project to transform government services
Dubai announces Eid Al Adha break for private schools
UAE approves innovative drug to treat uncontrolled blood pressure
